Wallace Y. Langdon

11.6k total citations · 2 hit papers
122 papers, 9.2k citations indexed

About

Wallace Y. Langdon is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Wallace Y. Langdon has authored 122 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 42 papers in Immunology and 24 papers in Oncology. Recurrent topics in Wallace Y. Langdon's work include Ubiquitin and proteasome pathways (20 papers), T-cell and B-cell Immunology (19 papers) and Protein Kinase Regulation and GTPase Signaling (16 papers). Wallace Y. Langdon is often cited by papers focused on Ubiquitin and proteasome pathways (20 papers), T-cell and B-cell Immunology (19 papers) and Protein Kinase Regulation and GTPase Signaling (16 papers). Wallace Y. Langdon collaborates with scholars based in Australia, United States and China. Wallace Y. Langdon's co-authors include Christine B.F. Thien, Herbert C. Morse, Jerry M. Adams, Hamid Band, Ivan Đikić, David D.L. Bowtell, Christopher E. Andoniou, Suzanne Cory, Timothy J. Blake and Philippe Soubeyran and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Wallace Y. Langdon

120 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor

1998 714 citations Wallace Y. Langdon et al. profile →
Cbl: many adaptations to regulate protein tyrosine kinases

2001 521 citations Christine B.F. Thien, Wallace Y. Langdon profile →

Peers

Countries citing papers authored by Wallace Y. Langdon

Since Specialization

Citations

This map shows the geographic impact of Wallace Y. Langdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wallace Y. Langdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wallace Y. Langdon more than expected).

Fields of papers citing papers by Wallace Y. Langdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wallace Y. Langdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wallace Y. Langdon. The network helps show where Wallace Y. Langdon may publish in the future.

Co-authorship network of co-authors of Wallace Y. Langdon

This figure shows the co-authorship network connecting the top 25 collaborators of Wallace Y. Langdon. A scholar is included among the top collaborators of Wallace Y. Langdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wallace Y. Langdon. Wallace Y. Langdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulation of immune responses by E3 ubiquitin ligase Cbl-b 2018 ·Cellular Immunology ·Rong Tang, Wallace Y. Langdon, Jian Zhang	58
2	Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction 2018 ·Immunity ·Xin Li, (unknown), Liying Gong, Haijun Tong, Virginie Calderon, Yue Li, Daisuke Kitamura, Ulf Klein, Wallace Y. Langdon, Fajian Hou, (unknown), Hua Gu	54
3	The targeting of human and mouse B lymphocytes by dasatinib 2015 ·Experimental Hematology ·Morten P. Oksvold, (unknown), (unknown), Samuel J. Taylor, Lise Forfang, June H. Myklebust, Erlend B. Smeland, Wallace Y. Langdon	6
4	E3 Ubiquitin Ligase Cbl-b Suppresses Proallergic T Cell Development and Allergic Airway Inflammation 2014 ·Cell Reports ·Guilin Qiao, Haiyan Ying, Yixia Zhao, (unknown), Hui Guo, (unknown), Zhenping Li, Julian Solway, Enxiang Tao, Y. Jeffrey Chiang, Stanley Lipkowitz, Josef Penninger, Wallace Y. Langdon, Jian Zhang	50
5	E3 ubiquitin ligase Cbl-b in innate and adaptive immunity 2014 ·Cell Cycle ·Qingjun Liu, Hong Zhou, Wallace Y. Langdon, Jian Zhang	55
6	The Loss of Cbl-Phosphatidylinositol 3-Kinase Interaction Perturbs RANKL-mediated Signaling, Inhibiting Bone Resorption and Promoting Osteoclast Survival 2010 ·Journal of Biological Chemistry ·Naga Suresh Adapala, Mary F. Barbe, Wallace Y. Langdon, Mary C. Nakamura, Alexander Y. Tsygankov, Archana Sanjay	32
7	Cbl-b Is a Negative Regulator of Inflammatory Cytokines Produced by IgE-Activated Mast Cells 2006 ·The Journal of Immunology ·Sonja E. Gustin, Christine B.F. Thien, Wallace Y. Langdon	31
8	Loss of c‐Cbl RING finger function results in high‐intensity TCR signaling and thymic deletion 2005 ·The EMBO Journal ·Christine B.F. Thien, (unknown), Yifan Zhan, Andrew M. Lew, Valentina Voigt, Christopher E. Andoniou, Wallace Y. Langdon	57
9	Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl 2004 ·Experimental Hematology ·Isabelle Gaston, Kara Johnson, Tsukasa Oda, Arun Bhat, (unknown), Wallace Y. Langdon, (unknown), Michael W. Deininger, Brian Druker	7
10	Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor 2003 ·Oncogene ·Morten P. Oksvold, Christine B.F. Thien, (unknown), Andrew Chantry, Henrik S. Huitfeldt, Wallace Y. Langdon	44
11	RING Finger Mutations that Abolish c-Cbl-Directed Polyubiquitination and Downregulation of the EGF Receptor Are Insufficient for Cell Transformation 2001 ·Molecular Cell ·Christine B.F. Thien, Francesca Walker, Wallace Y. Langdon	145
12	Mutation of the c-Cbl TKB Domain Binding Site on the Met Receptor Tyrosine Kinase Converts It into a Transforming Protein 2001 ·Molecular Cell ·Pascal Peschard, Tanya M. Fournier, Louie Lamorte, Monica A. Naujokas, Hamid Band, Wallace Y. Langdon, (unknown)	346
13	Suppression of Apoptosis Induced by Growth Factor Withdrawal by an Oncogenic Form of c-Cbl 2001 ·Journal of Biological Chemistry ·Elizabeth G. Hamilton, Kyle M. Miller, Karen M. Helm, Wallace Y. Langdon, Steven M. Anderson	18
14	Fyn, Yes, and Syk Phosphorylation Sites in c-Cbl Map to the Same Tyrosine Residues That Become Phosphorylated in Activated T Cells 1998 ·Journal of Biological Chemistry ·Elena A Feshchenko, Wallace Y. Langdon, Alexander Y. Tsygankov	147
15	Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase 1997 ·Oncogene ·Suresh Kumar Jain, Wallace Y. Langdon, Lyuba Varticovski	53
16	Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl 1997 ·Oncogene ·Christine B.F. Thien, Wallace Y. Langdon	51
17	A Novel Phosphotyrosine-binding Domain in the N-terminal Transforming Region of Cbl Interacts Directly and Selectively with ZAP-70 in T Cells 1996 ·Journal of Biological Chemistry ·Mark Lupher, Kris A. Reedquist, Sachiko Miyake, Wallace Y. Langdon, Hamid Band	179
18	The cbl oncogene: a novel substrate of protein tyrosine kinases 1995 ·Australian and New Zealand Journal of Medicine ·Wallace Y. Langdon	33
19	Oncogene Cooperation and B-Lymphoid Tumorigenesis in Eµ-myc Transgenic Mice 1989 ·Hämatologie und Bluttransfusion ·Warren S. Alexander, Olivier Bernard, Wallace Y. Langdon, A. W. Harris, Jerry M. Adams, Suzanne Cory	2
20	Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr. 1985 ·The Journal of Experimental Medicine ·Herbert C. Morse, J B Roths, Wendy F. Davidson, Wallace Y. Langdon, T. N. Fredrickson, Janet W. Hartley	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact